Paricalcitol

FDA Approved: * September 27, 2013
Pharm Company: * TEVA PHARMS
Category: Thyroid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Paricalcitol Overview

Paricalcitol (chemically it is 19-nor-1,25-(OH)2-vitamin D2. Marketed by Abbott Laboratories under the trade name Zemplar) is a drug used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic renal failure. It is an analog of 1,25-dihydroxyergocalciferol, the active form of vitamin D2 (ergocalciferol). Contents 1 Medical uses 2 Adverse effects 2.1 Contraindications 2.2 Interactions 2.3 Overdose 3 Mechanism...

Read more Paricalcitol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Paricalcitol

Recent Paricalcitol Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Paricalcitol
  • Capsule: 1mcg, 1ugm, 2mcg, 2ugm, 4mcg, 4ugm
  • Injection: 0.002mg/ml, 0.005mg/ml, 0.01mg/2ml (0.005mg/ml), 0.04mcg/kg To 0.1mcg/kg, 10mcg/2ml, 10mcg/ml, 2mcg/ml, 5mcg/ml
  • Solution: 0.002mg/ml (0.002mg/ml), 0.005mg/ml (0.005mg/ml), 0.01mg/2ml (0.005mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Paricalcitol: (72 results)

Showing the first 20, Sorted by National Drug Code
  • 0093-7656 Paricalcitol 1 Mcg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0093-7657 Paricalcitol 2 Mcg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0093-7658 Paricalcitol 4 Mcg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0143-9596 Paricalcitol 5 ug/ml Intravenous Injection by West-ward Pharmaceutical Corp
  • 0143-9624 Paricalcitol 5 ug/ml Intravenous Injection by West-ward Pharmaceutical Corp
  • 0143-9625 Paricalcitol 2 ug/ml Intravenous Injection by West-ward Pharmaceutical Corp
  • 0409-1007 Paricalcitol 2 ug/ml Intravenous Injection, Solution by Hospira, Inc.
  • 0409-1008 Paricalcitol 5 ug/ml Intravenous Injection, Solution by Hospira, Inc.
  • 10888-5001 Paricalcitol 1 ug/1 Oral Capsule, Liquid Filled by Banner Pharmacaps
  • 10888-5002 Paricalcitol 2 ug/1 Oral Capsule, Liquid Filled by Banner Pharmacaps
  • 10888-5003 Paricalcitol 4 ug/1 Oral Capsule, Liquid Filled by Banner Pharmacaps
  • 16729-310 Paricalcitol 2 ug/ml Intravenous Injection, Solution by Accord Healthcare, Inc.
  • 16729-311 Paricalcitol 5 ug/ml Intravenous Injection, Solution by Accord Healthcare, Inc.
  • 17478-033 Paricalcitol 5 ug/ml Intravenous Injection, Solution by Akorn, Inc.
  • 25000-012 Paricalcitol 1 ug/1 Oral Capsule, Liquid Filled by Marksans Pharma Limited
  • 25000-014 Paricalcitol 2 ug/1 Oral Capsule, Liquid Filled by Marksans Pharma Limited
  • 25000-017 Paricalcitol 4 ug/1 Oral Capsule, Liquid Filled by Marksans Pharma Limited
  • 42608-0006 Paricalcitol 1 ug/1 Oral Capsule, Gelatin Coated by Catalent U.k. Packaging Limited
  • 43598-562 Paricalcitol 5 ug/ml Intravenous Injection, Solution by Dr. Reddy's Laboratories Inc
  • 43598-563 Paricalcitol 2 ug/ml Intravenous Injection, Solution by Dr. Reddy's Laboratories Inc
  • 52 more results ...

Other drugs which contain Paricalcitol or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 21 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA